Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 2, 1999, Pages 774-781

  Kuroki, Toshihide ^a   Meltzer, Herbert Y ^b   Ichikawa, Junji ^b  

^a SAGA UNIVERSITY   (Japan)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPEROZIDE; CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SEROTONIN RECEPTOR; SULPIRIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DOPAMINE RELEASE; DRUG MECHANISM; MALE; MICRODIALYSIS; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE; EXTRACELLULAR SPACE; KINETICS; MALE; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0033019791     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Andersson JL, Nomikos GG, Marcus M, Hertel P, Mathé JM and Svensson TH (1995) Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic systems. Naunyn-Schmiedeberg's Arch Pharmacol 352:374-385.
2. Arvanitis LA, Miller BG and The Seroquel Trial 13 Study Group (1997) Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo. Biol Psychiatry 42:233-246.
3. 2 mRNA. Brain Res 564:203-219.
4. Bymaster FP, Calligaro DO, Falcone JF, Marsh FD, Moore NA, Tye NC, Seeman P and Wong DT (1996a) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96.
5. Bymaster FP, Hemrick-Luecke SK, Perry KW and Fuller RW (1996b) Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, α1-adrenergic and muscarinic receptors in vivo in rats. Psychopharmacology 124:87-94.
6. Cass WA and Gerhardt GA (1995) In vivo assessment of dopamine uptake in rat medial prefrontal cortex: Comparison with dorsal striatum and nucleus accumbens. J Neurochem 65:201-207.
7. Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GA, Labelle A, Beauclair L and Arnott W (1993) A Canadian multicentre placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of schizophrenic patients. J Clin Pharmacol 13:25-40.
8. Davis KL, Kahn RS, Grant K and Davidson M (1991) Dopamine in schizophrenia: A review and reconceptualization. Am J Psychiatry 148:1474-1486.
9. Deutch AY, Moghaddam B, Innis RB, Krystal JH, Aghajanian GK, Bunney BS and Charney DS (1991) Mechanisms of action of atypical antipsychotic drugs: Implications for novel therapeutic strategies for schizophrenia. Schizophr Res 4:121-156.
10. Deutch AY, Bourdelais AJ and Zahm DS (1993) The nucleus accumbens core and shell: Accumbal compartments and their functional attributes, in Limbic Motor Circuit and Neuropsychiatry (Kalivas PW and Barnes CD eds) pp 45-88, CRC Press, Boca Raton.
11. Green MF, Marshall Jr BD, Wirshing WC, Ames D, Marder SR, McGurk S, Kern RS and Mintz J (1997) Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry 154:799-804.
12. Hagger C, Buckley P, Kenny JT, Friedman L, Ubogy D and Meltzer HY (1993) Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine. Br J Psychiatry 34:702-712.
13. Hertel P, Nomikos GG, Iurlo M and Svensson TH (1996) Risperidone: Regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology 124:74-86.
14. Jacobs BL and Azmitia EC (1992) Structure and function of the brain serotonin system. Physiol Rev 72:165-229.
15. 2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 95:735-740.
16. Kane J, Hönigfeld G, Singer J and Meltzer HY (1988) Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 48:789-796.
17. 1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex. Brain Res 743:357-361.
18. 2 receptors. Psychopharmacology 112:S40-S54.
19. Mauri MC, Bravin S, Bitetto A, Rudelli R and Invernizzi G (1996) A risk-benefit assessment of sulpiride in the treatment of schizophrenia. Drug Safety 14:288-298.
20. Meltzer HY (1995) The concept of atypical antipsychotics, in Advances in the Neurobiology of Schizophrenia, vol 1 (Den Boer JA, Westenberg HGM and Van Praag HM eds) pp 265-273, Wiley and Sons, London.
21. 1 values. J Pharmacol Exp Ther 251:238-246.
22. Moghaddam B and Bunney BS (1990) Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study. J Neurochem 54:1755-1760.
23. Murphy BL, Arnsten AFT, Goldman-Rakic PS and Roth RH (1996) Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA 93:1325-1329.
24. Nomikos GG, Iurlo M, Andersson JL, Kimura K and Svensson TH (1994) Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology 115:147-156.
25. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates Academic Press, New York.
26. Pehek EA and Yamamoto BK (1994) Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J Neurochem 63:2118-2124.
27. Pettersson E (1995) Studies of four novel diphenylbutylpiperazinepyridyl derivatives on release and inhibition of reuptake of dopamine, serotonin and noradrenaline by rat brain in vitro. Eur J Pharmacol 282:131-135.
28. Robinson TE and Whishaw IQ (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: A microdialysis study in freely moving rats. Brain Res 450:209-224.
29. 1C receptors. J Pharmacol Exp Ther 260:1361-1365.
30. 4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology 120:365-368.
31. 1 dopamine receptors in prefrontal cortex: Involvement in working memory. Science (Wash DC) 251:947-950.
32. 2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur J Pharmacol 283:273-279.
33. Schotte A, Janssen PFM, Gommeren W, Luyten WHML, Van Gompel P, Lesage AS, DeLoore, K and Leysen JE (1996) Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology 124:57-73.
34. 4 receptor varies with the affinity of the competing radioligand. Eur J Pharmacol Mol Pharmacol Sect 291:59-66.
35. 2 receptors. J Pharmacol Exp Ther 266:1374-1384.
36. Tollefson GD and Sanger TM (1997) Negative symptoms: A path analytic approach to a double-blind, placebo-and haloperidol-controlled clinical trial with olanzapine. Am. J Psychiatry 154:466-474.
37. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 98:45-50.
38. Volonté M, Monferini E, Cerutti M, Fodritto F and Borsini F (1997) BIMG 80, a novel potential antipsychotic drug: Evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex. J Neurochem 69:182-190.
39. Weinberger DR and Lipska BK (1995) Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: A search for common ground. Schizophr Res 16:87-110.
40. Westerink BH and DeVries JB (1989) On the mechanism of neuroleptic induced increase in striatal dopamine release: Brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci Lett 99:197-202.